Biomedical Research and Development Price Index (BRDPI) Survey

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form Not applicable Biomedical Research and Development Price Index (BRDPI) Survey	Form and Instruction	Modified	Available
NIHnoteonresponserate.doc	Supplementary Document	Uploaded 2008-02-25	Available
Final Supporting statementA.doc	Supporting Statement A	Uploaded 2008-02-25	Available
Corrected.FRN.0608.0069.htm	Supplementary Document	Uploaded 2008-02-08	Available
BRDPI Survey Letter.pdf	Supplementary Document	Uploaded 2008-01-31	Available
Final Supporting statementB.doc	Supporting Statement B	Uploaded 2008-02-25	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
3740	Biomedical Research and Development Price Index (BRDPI) Survey	Form and Instruction	Modified

ICR Details

OMB Control No: 0608-0069	ICR Reference No: 200711-0608-001
Status: Historical Inactive	Previous ICR Reference No: 200501-0608-001
Agency/Subagency: DOC/EASA	Agency Tracking No:
Title: Biomedical Research and Development Price Index (BRDPI) Survey
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Improperly submitted and continue	Conclusion Date: 04/07/2008
	Date Received in OIRA: 02/08/2008
Terms of Clearance: Per our discussions, BEA may immediately resubmit this ICR and amend it with proposed IC documents that fully reflect the 2008 collection cycle.

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2008	36 Months From Approved	05/31/2008
Responses	105	0	105
Time Burden (Hours)	1,176	0	1,176
Cost Burden (Dollars)	43,982,000	0	43,982,000

---

Abstract: The survey is used to obtain fiscal year data on expenditures relating to biomedical research and development awards and to update and rebase the BRDPI. Data are obtained from organizations which are recipients of biomedical research and development awards from the National Institutes of Health.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	72 FR 49254	08/28/2007
30-day Notice:	Federal Register Citation:	Citation Date:
	73 FR 6114	02/01/2008
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Biomedical Research and Development Price Index (BRDPI) Survey	Not applicable	Biomedical Research and Development Price Index (BRDPI) Survey

---

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: There is a increase adjustment to the respondents/responses and hour burden. The cost burden adjusted to ‘no cost’ to respondents, mistakenly included in previous submission.

---

Annual Cost to Federal Government: $46,000

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 02/08/2008

---